Could a simple blood test predict statin muscle pain?

NCT ID NCT07511686

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed observational study from Latvia looked at whether statin-related muscle symptoms are linked to problems in fat metabolism in muscle cells. Researchers measured acylcarnitine levels in blood and muscle samples from 38 adults, comparing those with statin-related muscle pain, those taking statins without symptoms, and people not taking statins. The goal was to see if acylcarnitine levels could help explain or predict muscle side effects from statins.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STATIN ADVERSE REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Latvia (Faculty of Medicine and Institute of Cardiology and Regenerative Medicine)

    Riga, Latvia

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help explain why some people get muscle pain from statins and point toward ways to predict or manage this side effect.

What could go wrong

This is a small, observational study (38 participants) that only measures biological markers, not a treatment. Results may not apply to all populations or lead to direct clinical changes.

Conditions

The condition(s) this trial relates to.

drug-induced myopathy muscle tissue disorder statin toxicity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.